Abstract
To investigate whether hepatitis viral DNA load at 24 wk of treatment predicts response at 96 wk in patients with chronic hepatitis B. A total of 172 hepatitis B envelope antigen (HBeAg)-positive chronic hepatitis B patients who received initial treatment at 16 tertiary hospitals in Hunan Province, China were enrolled in this study. All patients received conventional doses of lamivudine and adefovir dipivoxil, telbivudine, entecavir dispersible tablets, or entecavir tablets for 96 wk. Patients who used other antiviral drugs or antitumor and immune regulation therapy were excluded. Patients were stratified into three groups according to their viral DNA load at 24 wk: < 10 IU/mL (group 1), 10-103 IU/mL (group 2), and > 103 IU/mL (group 3). Correlations of 24-wk DNA load with HBeAg negative status and HBeAg seroconversion at 96 wk were analyzed. Receiver operating characteristic curve analysis was used to test the predictive value of the HBV DNA load at 24 wk for long-term response. The rates of conversion to HBeAg negative status and HBeAg seroconversion rates were 53.7% and 51.9%, respectively, in group 1; 35.21% and 32.39% in group 2; and 6.38% and 6.38% in group 3. The receiver operating characteristic curves for the three sub...Continue Reading
References
Mar 12, 2004·The New England Journal of Medicine·Don Ganem, Alfred M Prince
Mar 24, 2005·Intervirology·Kenji IkedaHiromitsu Kumada
Mar 15, 2006·Gastroenterology·Uchenna H IloejeUNKNOWN Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-In HBV (the REVEAL-HBV) Study Group
Jan 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henry Lik-Yuen ChanTony Shu-Kam Mok
Oct 4, 2008·The New England Journal of Medicine·Jules L Dienstag
Nov 26, 2008·Gastroenterology·Yun-Fan LiawUNKNOWN GLOBE Study Group
Apr 7, 2009·Journal of Hepatology·Stefan ZeuzemNikolai V Naoumov
Nov 19, 2009·The American Journal of Gastroenterology·James FungMan-Fung Yuen
Jun 16, 2011·Alimentary Pharmacology & Therapeutics·Y LiangH L-Y Chan
Mar 23, 2012·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver
Jul 6, 2014·Antiviral Therapy·Xiaodong LiDongping Xu
Aug 19, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Florian van BömmelAnke Edelmann
Jun 1, 2012·Hepatology International·Yun-Fan LiawMasao Omata
Aug 1, 2014·Acta Pharmaceutica Sinica. B·Jinhong ChangJu-Tao Guo
Feb 28, 2016·Advances in Therapy·Xieer LiangKamal Hamed
Apr 15, 2016·Journal of Gastroenterology and Hepatology·Huilan ZhuZhenhua Zhang
May 22, 2016·Hepatology International·Fabien ZoulimHarry L A Janssen
Jun 16, 2016·Alimentary Pharmacology & Therapeutics·C-L Lin, J-H Kao
Nov 3, 2016·Journal of Viral Hepatitis·M Martinot-PeignouxP Marcellin